| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 12.879 | 15.645 | 913 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 12.879 | 15.645 | 913 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 3.402 | 4.311 | 1.236 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | 9.477 | 11.333 | -323 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | 9.091 | 10.864 | -351 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Enea Bioengineering Srl-D
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 9.263 | 1.869 | 330 | 324 | 318 | 311 | 311 | 311 | 309 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.093 | 0 | 77 | 75 | 74 | 72 | 72 | 72 | 72 |
| Cash | - | 7.170 | 1.869 | 254 | 249 | 244 | 239 | 239 | 239 | 237 |
| Shareholders Funds | - | 45 | 44 | -308 | -302 | -296 | -289 | -290 | -289 | -288 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 9.219 | 1.825 | 638 | 625 | 614 | 600 | 602 | 600 | 597 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Enea Bioengineering Srl-D